Dean's Executive Forum Speaker

Ryan Cohlhepp (PharmD 2000)

VP U.S. Marketing, Operations & Analytics
Takeda Oncology

Ryan Cohlhepp is currently the Vice President of Marketing, Operations & Analytics for Takeda Oncology. This includes responsibility for both of Takeda’s approved therapies VELCADE and NINLARO. He led the U.S. Commercial launch for NINLARO which was approved by the FDA in four months under fast track status. Prior to his current role, Ryan worked in the Global Development Division as a Global Team Leader overseeing the development of Takeda’s prostate cancer portfolio in addition to several early stage molecules.

Over the course of his career, Ryan has led the commercial efforts for numerous pipeline products ranging from pre-clinical to Phase III drugs, including co-development partnerships. He has over 15 years of experience in the pharmaceutical and biotech industries, having started his career with Roche Pharmaceuticals (currently Genentech) in their commercial organization. He held positions of increasing responsibility for Roche in both the sales and marketing organizations (U.S. and Global). 

Ryan received his Doctorate of Pharmacy from Purdue University in 2000. He continues his involvement with the University as a member of the Dean’s Advisory Council for the College of Pharmacy.




Mega Menu Visual Content